Related Experiment Videos
[Aggravation and relapse of tuberculosis: From a viewpoint for management of patients (author's transl)]
Kekkaku : [Tuberculosis]
|December 1, 1976
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society·2014
Effects of acute citalopram treatment on the methamphetamine-induced locomotor activity.
Progress in neuro-psychopharmacology & biological psychiatry·2001
[A case of breast cancer with bone marrow and liver metastases responding completely to low-dose weekly paclitaxel combined with toremifene].
Gan to kagaku ryoho. Cancer & chemotherapy·2001
[CLINICAL INVESTIGATION OF 6 CASES OF TUBERCULOUS SPONDYLITIS].
Kekkaku : [Tuberculosis]·2019
[CONTROLLING TUBERCULOSIS IN FOREIGN-BORN PERSONS IN JAPAN].
Kekkaku : [Tuberculosis]·2019
[NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE].
Kekkaku : [Tuberculosis]·2019
[MYCOBACTERIOSIS ASSOCIATED WITH ADMINISTRATION OF BIOLOGICS].
Kekkaku : [Tuberculosis]·2019
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026